Protecting Animals and Humans
At Boehringer Ingelheim we are committed to ensuring the continued availability of our products for patients, customers and animals during the pandemic.
Search
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
Women in STEM 2022
Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. Click here to find out more.
Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim
Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities.
COVID-19 Volunteering in the U.S.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
History
Learn about the history of Boehringer Ingelheim, starting with Albert Boehringer founding the company in 1885 when it employed just 28 people.
Vision & Values
Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: value through Innovation, the central concept of our corporate vision.
Trust Through Transparency
Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
India
In India, Boehringer Ingelheim is one the fastest growing multinational pharmaceutical companies. Find out more about our presence in India here.
1948-1988
Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.
Boehringer Ingelheim China for a green future
Together with all other functions, Fangya Qiang oversees the MORE GREEN programme at Boehringer Ingelheim’s Chinese locations. Click here to learn more.
COVID-19 Global Access Commitment with Gates Foundation
Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing a communiqué with the Bill & Melinda Gates Foundation.
COVID-19 Once a nurse always a nurse
Colleagues Anne Hunstad and Maarten van Helvoirt, both educated nurses, support the health care workers during the COVID-19 pandemic. Learn more.
COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. Read more.
Purchasing
Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too.
Corporate Profile
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. Learn more about our company here.
Sustainable Development
Discover our 'Sustainable Development - For Generations' journey. The journey not only involves the current generation but future ones to come.
COVID-19 Volunteering in India
Learn about our employees in India volunteering during COVID-19, including Rashmi Suvarna, Head of Procurement at Boehringer Ingelheim India.
Speak up
We are committed to conducting business with integrity and in compliance with applicable laws, regulations, company policies and procedures. Find out more.
World Patient Safety Day 2021
As a sign of support for World Patient Safety Day, Boehringer Ingelheim lights up buildings in orange. Click here to learn and find out more.
Press Releases
Click here to find the latest press releases from Boehringer Ingelheim on animal health, prescription medicine, pipeline and corporate news.
Featured Stories
Click here to see Boehringer Ingelheim's latest featured stories to help provide inspiration for both human and animal health and well-being.
Products
Click here for an overview of our human and animal health products. We provide a wide range of products to help improve the lives of humans and animals.
COVID-19 Germany Together through the Pandemic
Boehringer Ingelheim enabled all 51,000 employees worldwide to take ten days off for voluntary work – with full payment. Click here to learn more.